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Objective To determine the completeness and diagnostic validity of
myocardial infarction recording across four national health record sources
in primary care, hospital care, a disease registry, and mortality register.
Design Cohort study.
Participants 21 482 patients with acute myocardial infarction in England
between January 2003 and March 2009, identified in four prospectively
collected, linked electronic health record sources: Clinical Practice
Research Datalink (primary care data), Hospital Episode Statistics
(hospital admissions), the disease registry MINAP (Myocardial Ischaemia
National Audit Project), and the Office for National Statistics mortality
register (cause specific mortality data).
Setting One country (England) with one health system (the National
Health Service).
Main outcome measures Recording of acute myocardial infarction,
incidence, all cause mortality within one year of acute myocardial
infarction, and diagnostic validity of acute myocardial infarction compared
with electrocardiographic and troponin findings in the disease registry
(gold standard).
Results Risk factors and non-cardiovascular coexisting conditions were
similar across patients identified in primary care, hospital admission,
and registry sources. Immediate all cause mortality was highest among
patients with acute myocardial infarction recorded in primary care, which
(unlike hospital admission and disease registry sources) included patients
who did not reach hospital, but at one year mortality rates in cohorts
from each source were similar. 5561 (31.0%) patients with non-fatal
acute myocardial infarction were recorded in all three sources and 11
482 (63.9%) in at least two sources. The crude incidence of acute
myocardial infarction was underestimated by 25-50% using one source
compared with using all three sources. Compared with acute myocardial
infarction defined in the disease registry, the positive predictive value of
acute myocardial infarction recorded in primary care was 92.2% (95%
confidence interval 91.6% to 92.8%) and in hospital admissions was
91.5% (90.8% to 92.1%).
Conclusion Each data source missed a substantial proportion (25-50%)
of myocardial infarction events. Failure to use linked electronic health
records from primary care, hospital care, disease registry, and death
certificates may lead to biased estimates of the incidence and outcome
of myocardial infarction.
Trial registration NCT01569139 clinicaltrials.gov.
Introduction
Electronic health records inform patient decision making and
policy and are increasingly used to define disease and the
outcomes of care in observational cohorts of genetic and
environmental factors1-4 and randomised trials.5-7 Recent
initiatives to expand the use of health records for research have
been announced in many countries,8-11 and in the United
Kingdom the National Health Service is now legally required
to evaluate patient outcomes.12 The UK government has also
recently announced plans to drive improvement in
cardiovascular disease care through use of information in linked
health records.13 In various settings across the world these
initiatives are being met by the linkage of electronic health
records from disparate sources. Underpinning these uses of
electronic health records is the need for a better understanding
of the quality of data within a single source as well as between
multiple sources. Indeed, it is a concern that electronic records
from one part of the health system, such as primary care, may
not capture health events occurring in other parts of the health
system, such as hospital care.
As part of the CArdiovascular disease research using LInked
Bespoke studies and Electronic health Records (CALIBER)
programme14 we carried out new linkage between records from
primary care,15 hospitals, an acute coronary syndrome registry,16
and death certificates. Although data from these types of source
are increasingly available in different countries,17 18 for acute
myocardial infarction the overlap between these four electronic
health record sources, patient risk factors, and subsequent
mortality have not been compared. Previous cross referencing
studies have typically compared one or two electronic sources,
such as coded hospital discharge diagnoses and cause of death,
with case note review,19-21 questionnaires to general
practitioners,22 or active case finding in a prospective consented
study1-24 (see supplementary table 1). Linkages with the national,
ongoing acute coronary syndrome registry allowed detailed
diagnoses of myocardial infarction (with coded
electrocardiographic findings and markers of myocardial
necrosis, not available in other sources) to be compared with
diagnoses in primary care and hospital admissions. Linkages
with primary care allowed evaluation of risk factors in patients
with a record of acute myocardial infarction in any source.
Linkages with the death record allowed evaluation of cause
specific mortality of myocardial infarction recorded in any
source, including among cases not admitted to hospital.
We compared the incidence, recording, agreement of dates and
codes, risk factors, and all cause mortality of acute myocardial
infarction recorded in primary care, hospital care, the national
acute coronary syndrome registry, and the national death
registry.
Methods
We used a cohort study design, identifying patients with acute
myocardial infarction in four prospectively collected, linked
electronic health record sources in England (the CALIBER
programme14). Briefly, the CALIBER linkage included
anonymised primary care electronic patient records from the
Clinical Practice Research Datalink15 (www.cprd.com, formerly
known as the General Practice Research Database), data on
hospital admissions from Hospital Episode Statistics, the
national registry of acute coronary syndromes (Myocardial
Ischaemia National Audit Project, MINAP),16 and the death
registry, curated by the Office for National Statistics (see
supplementary table 2).
Of the 630 primary care practices in Clinical Practice Research
Datalink, 244 consented to data linkage with Hospital Episode
Statistics, MINAP, and the Office for National Statistics. These
practices contained 3.9% of the population of England in 2006.
The linkage was carried out in October 2010 by a trusted third
party, using a deterministic match between NHS number, date
of birth, and sex. Overall, 96% of patients with a valid NHS
number were successfully matched.
Study population: patients with acute
myocardial infarction
We identified records of acute myocardial infarction with
reference to previously described definitions for each source.
In primary care, diagnoses are recorded using Read codes25 and
previous studies have published lists of Read codes used to
identify acute myocardial infarction.26 27 We identified
myocardial infarction using the 62 Read codes listed in
supplementary table 3. In Hospital Episode Statistics and the
Office for National Statistics death registry, diagnoses are coded
using the International Classification of Diseases, 10th revision28;
in commonwith previous studies,29we defined acute myocardial
infarction by ICD-10 codes I21 (acute myocardial infarction),
I22 (subsequent myocardial infarction), or I23 (current
complications following acute myocardial infarction). In
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Hospital Episode Statistics, to be included in our study
myocardial infarction had to be recorded as the primary
diagnosis in the first episode of an admission to hospital (where
the first episode refers to the first period of care for an admitted
patient overseen by a healthcare professional30). We performed
a sensitivity analysis to assess the influence of inclusion of
secondary diagnoses. In MINAP, ST elevation and non-ST
elevation myocardial infarction were identified using hospital
discharge diagnosis, markers of myocardial necrosis, and coded
electrocardiographic findings, in accordance with the
internationally agreed definition of myocardial infarction.31 For
MINAP and Hospital Episode Statistics, we took the hospital
admission date to represent the date of acute myocardial
infarction.
The study period was 1 January 2003 to 31 March 2009 (when
all record sources were concurrent) and confined to patients
who had been registered with their general practice for at least
a year and the practice had been submitting data for at least one
year that met Clinical Practice Research Datalink data quality
standards for continuity and plausibility of data recording. In
the main analysis we included only patients with at least one
record of admission to hospital in Hospital Episode Statistics
at any time (for any cause) as these patients were shown to be
linkable, but we conducted a sensitivity analysis including all
patients. We selected the first record of myocardial infarction
during the patient’s study period as the index event and
considered myocardial infarction records in the other data
sources as representing the same event if they were dated within
30 days of the index event.
Cardiovascular risk factors and
non-cardiovascular coexisting conditions
For patients with acute myocardial infarction we identified risk
factors recorded in primary care, including age, sex, social
deprivation,32 smoking, use of antihypertensives or lipid lowering
drugs, diabetes mellitus, Charlson comorbidity index,33 and
primary care consultation rate before the event. We used mean
measures of systolic blood pressure and total cholesterol and
high density lipoprotein cholesterol levels before myocardial
infarction along with age, sex, and smoking status (where these
variables were present) to estimate the 10 year Framingham risk
for acute myocardial infarction or coronary death.34 We used
these measures to compare the cohorts of myocardial infarction
identified in each data source.
Follow-up for mortality
We followed all patients with a record of myocardial infarction
in any source for one year for death as recorded in the Office
for National Statistics death registry. We categorised patients
as having fatal or non-fatal myocardial infarction by whether
they died of any cause within seven days of the myocardial
infarction. If a patient had a myocardial infarction record in
Clinical Practice Research Datalink, Hospital Episode Statistics,
or MINAP after their date of death, we considered that they
died on the day of their myocardial infarction.
Agreement in recording
If the time difference between the earliest date of acute
myocardial infarction in one source and the date in another
source was nomore than 30 days we considered that the records
of acute myocardial infarction in the different sources agreed.
A myocardial infarction recorded more than 30 days after the
earliest date was considered a new event and was not included,
ensuring that each patient appeared only once in the analysis.
We chose 30 days to account for any delay in recording of
myocardial infarction in primary care, assuming that any record
within 30 days of a hospital admission was likely to represent
the same event and anything after 30 days could feasibly be a
subsequent myocardial infarction. We carried out a sensitivity
analysis using a 90 day threshold.
Statistical analysis
Incidence
We estimated population based incidence rates of fatal and
non-fatal acute myocardial infarction using the denominator of
all adults in the CALIBER primary care population aged 18 and
over (2.2 million), followed up for a mean 4.1 years between
2003 and 2009. We used each of the data sources separately
and together to identify incident myocardial infarction, ending
the follow-up period for a patient on the date of their first
myocardial infarction during the study period, death, or
deregistration from the general practice.
Cardiovascular risk factors and
non-cardiovascular coexisting conditions
We compared patients with fatal and non-fatal acute myocardial
infarction identified in the four data sources for risk factors and
coexisting conditions recorded in primary care.
Death after acute myocardial infarction
We produced cumulative incidence curves for coronary and
non-coronary mortality for patients recorded in each data source
and comparedmortality using a Cox proportional hazards model
adjusted for age and sex.
Agreement in recording
We would expect patients who survived seven days after
myocardial infarction to be recorded in the primary care, disease
registry, and hospital admissions sources, and we assessed
agreement between these three sources in a Venn diagram. For
patients who died within seven days, we examined the
proportion recorded by each source but did not compare
agreement across all four sources as we would not expect the
hospital discharge data and disease registry to record patients
who died before reaching hospital.
In patients who did not have a record of acute myocardial
infarction in one or more data sources, we looked for other codes
that may have been used to describe the event. In the disease
registry, we looked for unstable angina or admission diagnoses
of any acute coronary syndrome. In primary care and hospital
discharge data, we sought other acute coronary syndromes,
coronary disease, chest pain, or other cardiac diagnoses (for
example, atrial fibrillation, heart failure, cardiac arrest). In
primary care data we also examined codes indicating contact
with secondary care. Where none of these codes was recorded,
we tabulated all recorded codes in the 30 days before and after
the date of myocardial infarction to see if there were any relevant
codes we had overlooked.
We performed a logistic regression analysis to establish whether
age, sex, deprivation, rate of primary care consultation, year of
myocardial infarction, or mortality at 30 days explained
suboptimal recording of acute myocardial infarction in primary
care, hospital discharge, or disease registry sources.
We calculated the positive predictive value of primary care or
hospital discharge diagnoses of acute myocardial infarction
among patients who also had a record in the acute coronary
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syndrome registry. Data were analysed using Stata 12 and R
2.14.1.35
Results
We identified 21 482 patients with fatal or non-fatal acute
myocardial infarction recorded in any of the four data sources.
Incidence
Among the single source crude estimates for incidence of
myocardial infarction, primary care data (Clinical Practice
Research Datalink) gave the highest estimate, of 187 per 100
000 patient years (95% confidence interval 184 to 190), followed
by hospital discharge data (Hospital Episode Statistics) with
154 per 100 000 patient years (152 to 157), acute coronary
syndrome registry (MINAP) with 115 per 100 000 patient years
(113 to 118), and death registry with 45 per 100 000 patient
years (43 to 46). Combining these three sources yielded an
estimate of 243 per 100 000 patient years (239 to 246, fig 1⇓).
The crude incidence of acute myocardial infarction was 25%
lower using only Clinical Practice Research Datalink and 50%
lower using onlyMINAP compared with using all three sources.
See supplementary figure 1 and table 4 for standardised
incidence by age, sex, and region.
Cardiovascular risk factors and comorbidity
Overall, the cohorts identified from the primary care, hospital,
and disease registry sources had a similar prevalence of
cardiovascular risk factors and comorbidities. However,
compared with those recorded in the acute coronary syndrome
registry or hospital discharge data only, patients with fatal or
non-fatal myocardial infarction recorded only in primary care
were on average two years younger andmore likely to be current
smokers and in the most deprived fifth (P<0.001 for these
comparisons, also see supplementary table 5). Patients recorded
by the death registry were older than patients recorded in the
other sources and had a higher burden of risk factors reflecting
their age. However, other demographic characteristics and
cardiovascular risk factors were broadly similar across patients
recorded in primary care and hospital care sources (table 1⇓,
also see supplementary table 5).
Death after acute myocardial infarction
Patients with myocardial infarction identified in the disease
registry had lower crude 30 day mortality (10.8%, 95%
confidence interval 10.2% to 11.4%) than those identified in
hospital care (13.9%, 13.3% to 14.4%) or in primary care
(14.9%, 14.4% to 15.5%, fig 2⇓). At one year, however,
mortality was similar in all three groups, at around 20%.
In the linked data, patients with acute myocardial infarction
recorded in only one source had higher mortality than those
recorded in more than one source (age and sex adjusted hazard
ratio 2.29, 95% confidence interval 2.17 to 2.42; P<0.001).
Among patients with myocardial infarction recorded in only
one source (Hospital Episode Statistics, Clinical Practice
Research Datalink, or MINAP), those recorded only in primary
care had the highest mortality on the first day but the lowest
mortality thereafter (see supplementary figures 2 and 3). Among
patients with myocardial infarctions recorded in one of Hospital
Episode Statistics orMINAP but not both, those inMINAP had
lower coronarymortality in the first month (age and sex adjusted
hazard ratio 0.33, 0.28 to 0.39, P<0.001) but similar mortality
for non-coronary events (1.12, 0.90 to 1.40, P=0.3). After the
first month, patients with myocardial infarctions recorded only
in primary care had about half the hazard of mortality of patients
with myocardial infarctions recorded in one of MINAP or
Hospital Episode Statistics (hazard ratio adjusted for age and
sex for coronary causes 0.49, 95% confidence interval 0.40 to
0.60, P<0.001 and for other causes 0.57, 0.49 to 0.67, P<0.001).
Of the 3518 patients with myocardial infarction recorded in any
of the four sources who died of any cause within seven days,
54.4% (n=1914) had a myocardial infarction code recorded in
primary care within 30 days. The underlying cause of death was
acute myocardial infarction in 2924 patients (83.0%); a further
164 patients (4.7%) had ischaemic heart disease recorded as the
underlying cause of death (ICD-10 code I20, I24, or I25), 60
(1.7%) had cerebrovascular disease (I60-I69), and 85 (2.4%)
had respiratory disease (J00-J99). However, 3375 of these 3518
patients (95.9%) had a coronary diagnosis (I20-I25) as either
the underlying cause or a secondary cause of death.
Fatal myocardial infarctions identified by death registry data
(underlying cause of death ICD-10 I21, I22, or I23, n=2919)
were unlikely to be recorded in hospital sources; 36.7%
(n=1072) were recorded in Hospital Episode Statistics and just
17.1% (n=498) in the MINAP disease registry within 30 days,
but 55.9% (n=1631) were recorded in primary care (see
supplementary table 6).
Non-fatal acute myocardial infarction:
agreement between record sources
Among the 17 964 patients with at least one record of non-fatal
acute myocardial infarction, 13 380 (74.5%) were recorded by
Clinical Practice Research Datalink, 12 189 (67.9%) byHospital
Episodes Statistics, and 9438 (52.5%) byMINAP. Overall, 5561
(31.0%) of patients had the event recorded in all three sources
and 11 482 (63.9%) in at least two sources (fig 3⇓). When we
extended the recording window from 30 days to 90 days, the
proportion recorded in all three sources increased only slightly,
to 32.0% (n=5747). When we included patients who had never
had a record of a hospital admission in Hospital Episode
Statistics, the proportion of non-fatal myocardial infarctions
recorded in all three sources decreased slightly to 30.0%
(5561/18 536) and the proportion recorded only in primary care
increased from 17.7% (3188/17 964) to 20.3% (3760/18 536).
A sensitivity analysis in which the Hospital Episode Statistics
case definition included secondary diagnoses of myocardial
infarction (where myocardial infarction was not the reason for
admission) produced only a slight increase in the proportion
recorded in all three sources (5812/18 283, 32.0%), and
identified 306 additional myocardial infarctions that were not
in any other source.
The exact date of admission agreed in over 80% of 6851 patients
with acute myocardial infarction recorded in both hospital care
and disease registry sources (see supplementary figure 4), but
the date recorded in primary care was the same as the disease
registry admission date or hospital admission date for only 50%
of patients (n=15 753). There was a smaller peak in primary
care recording between five and seven days after admission.
When the time windowwas extended to 90 days, there was little
change in these proportions.
Among patients with non-fatal myocardial infarction, 88.0%
(8304/9438) of those recorded inMINAP and 89.1% (10 859/12
189) recorded in Hospital Episode Statistics had a Read code
for any cardiac diagnosis or chest pain within 30 days in primary
care, and in over 70% the Read code statedmyocardial infarction
(see supplementary table 6). Only 25.1% (3364/13 380) of the
non-fatal myocardial infarctions recorded in primary care stated
the type—that is, ST elevation or non-ST elevation—compared
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with 100% for the disease registry. If a non-fatal myocardial
infarction was recorded in primary care, hospital discharge data
recorded a cardiac diagnosis within 30 days in 84.9% (11 355/13
380) of patients, with a primary diagnosis of myocardial
infarction in 72.6% (9720/13 380). However, this proportion
varied depending on the Read term used to identify myocardial
infarction in primary care; for terms that state the anatomical
location (for example, acute anterolateral infarction) it was
around 80% but was lower for less precise terms. For example,
of the 74 patients with the Read term “heart attack,” only 32
(43%) had a primary hospital diagnosis of myocardial infarction.
Supplementary tables 7-9 describe the agreement between
sources according to the way in which acute myocardial
infarction was recorded in each source.
Positive predictive value
For primary care or hospital discharge patients with an
associated record in the disease registry (MINAP), the positive
predictive value of the acute myocardial infarction diagnosis
(the probability that the diagnosis recorded in the disease registry
was myocardial infarction rather than unstable angina or a
non-cardiac diagnosis) was 92.2% (6660/7224, 95% confidence
interval 91.6% to 92.8%) in primary care and 91.5% (6851/7489,
90.8% to 92.1%) in hospital care (table 2⇓). Eighty five per cent
of patients recorded in primary care and hospital discharge
(7386/8707) had a record of raised cardiac markers and half
(3766/8707) had a record of ST segment elevation on
electrocardiography.
Non-fatal acutemyocardial infarction: reasons
for disagreement
Compared with patients who had a record of acute myocardial
infarction in only one source, those with records in multiple
sources had a lower rate of primary care consultation before the
event, were younger, were more likely to be male, and more
likely to have experienced acute myocardial infarction in one
of the later years of data collection. Among patients with
myocardial infarction recorded in primary care, an additional
record in Hospital Episode Statistics or MINAP was strongly
associated with increased mortality at 30 days (see
supplementary table 10).
Discussion
We compared electronic health records on one major disease
event—acute myocardial infarction—across four English,
ongoing sources of health record data: primary care (Clinical
Practice Research Datalink), hospital admissions (Hospital
Episode Statistics), a quality improvement disease registry
(Myocardial Ischaemia National Audit Project, MINAP), and
the death registry (Office for National Statistics). In over 20
000 patients each data source missed a substantial proportion
of myocardial infarction events. We also found evidence for the
validity of myocardial infarction recording across all sources,
in terms of risk factor profiles and mortality at one year. Taken
together, these findings support the wider use of linkage of
multiple record sources by clinicians, policy makers, and
researchers.
Fatal myocardial infarction
Both primary care and death registry data can be used to capture
fatal myocardial infarction occurring out of hospital among
people without a record of myocardial infarction in the Hospital
Episode Statistics or disease registry (MINAP). The death
registry is a useful source of fatal acute myocardial infarction
for research, as most (83.0%) patients who were identified as
having acute myocardial infarction in any of the data sources
and died within seven days had myocardial infarction recorded
as their underlying cause of death. These figures agree with
results from the Oxford Record Linkage Study, where among
5686 patients admitted to hospital with myocardial infarction
85.2% who died within 30 days had myocardial infarction
recorded as the underlying cause of death.36
Non-fatal myocardial infarction
Primary care capturesmost cases, but all sources
miss non-fatal myocardial infarction
We found that each record source misses cases. Only one third
of non-fatal myocardial infarctions were recorded in all three
data sources (primary care, hospital admissions, and disease
registry) and two thirds were recorded in at least two sources.
Clinical Practice Research Datalink was the single most
complete source of non-fatal myocardial infarction records (one
quarter of all non-fatal myocardial infarction events not
recorded), Hospital Episode Statistics missed one third, and
MINAP missed nearly half (fig 3). This agrees with the results
of other studies; a two source study of myocardial infarction in
Scotland (see supplementary table 1) compared the incidence
based on primary care records with that based on hospital data
and showed that in combination they provided the highest
estimates of incidence.37 Further two source comparisons in
Australia,38Denmark,39 and the Netherlands24 (see supplementary
table 1) have shown that hospital records alone underestimate
the true incidence of myocardial infarction. Despite the low
sensitivity of these data sources, in our study the positive
predictive value of myocardial infarction records in primary
care and hospital admission sources were over 90% compared
with the disease registry gold standard based on the international
definition of myocardial infarction (table 2).
However, some of the myocardial infarctions recorded only in
primary care are likely to be historical diagnoses because the
associated mortality rate in the first month is much lower than
those also recorded in hospital sources (see supplementary figure
2). Our results using cross referencing of electronic health
records in 20 000 patients are consistent with previous manual
approaches to validation in primary care, which cross reference
a few hundred patients with disease diagnoses recorded using
Read codes against anonymised free text, death certificates,
paper medical records, or hospital discharge summaries, or
questionnaires to general practitioners.40-48 Our much larger
sample size, however, allowed us to evaluate individual Read
terms that are used to record myocardial infarction. This type
of validation has not been done previously for myocardial
infarction and may be relevant to other common conditions that
can be recorded using a variety of codes, such as stroke.49
Hospital admission data
To our knowledge, no studies have examined the positive
predictive value of ICD-10 coded myocardial infarction
diagnosis in hospital admission data against an ongoing disease
registry. We found that 62.8% of non-fatal myocardial
infarctions recorded in primary care and 72.6% recorded in the
disease registry were recorded by hospital admissions data. This
is consistent with a single electronic health record source
(Hospital Episode Statistics ICD-10 I21 and I22) capturing 53%
of myocardial infarctions in an investigator led cohort with
active follow-up.50
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Disease registry and maximising true positives
The strengths of the disease registry MINAP lie in the fact that
its diagnostic records (troponin values, electrocardiographic
findings, and cardiologist diagnosis of ST elevation and non-ST
elevation myocardial infarction) are not available in other
sources, which offer validated endpoints electronically from all
hospitals in England andWales. An acute myocardial infarction
recorded in MINAP is thus an electronic health record gold
standard, as a myocardial infarction recorded by a registry is
likely to fulfil international diagnostic criteria.16 The registry
may be important for detecting endpoints in cohort studies and
trials, where false positives can dilute any observed effect and
reduce the power of a study. Furthermore, in such studies it has
been shown that avoiding false positives is more important than
avoiding false negatives.51Validation of myocardial infarctions
recorded by primary care and hospital admissions against those
recorded by the disease registry showed a positive predictive
value of over 90%,making them suitable for detecting endpoints
in cohort studies and trials, where poor endpoint resolution can
dilute any observed effect and reduce the power of a study.51
The positive predictive value was not 100% because some
myocardial infarction records in primary care may actually have
been related to unstable angina or chest pain of an unknown
cause.
Limitations of this study
Our data were from a sample of 244 English general practices
contributing to the Clinical Practice Research Datalink.
However, the primary care patients included in this CALIBER
study are representative of the UK population. Furthermore,
patients in practices that participated in the linkage were
representative of the Clinical Practice Research Datalink as a
whole in terms of age, social deprivation, body mass index, and
prescription of key drugs.52 Hospital admissions with linked
primary care data were also representative of all admissions to
hospital in England in terms of the distribution of age, sex, and
diagnostic group.53 The UK life science strategy aims to increase
the proportion of the UK population with primary care data
available for research linked electronic health record through
the Clinical Practice Research Datalink.15 A second limitation
concerns the generalisability of our findings for the quality of
primary care data. Practices contributing data to the Clinical
Practice Research Datalink are advised of recording guidelines
and their data are accepted only when they meet standards of
data completeness,15 so they are likely to record disease events
better than general practices that do not contribute. Our estimates
of agreement from this study may therefore be higher than for
practices that do not contribute to the Clinical Practice Research
Datalink. Thirdly, our validation of Hospital Episode Statistics
and Clinical Practice Research Datalink myocardial infarctions
against MINAPwas (inherently) limited to the subset of patients
with a MINAP record, and caution must be exercised in
extending these conclusions to patients with myocardial
infarctions without a MINAP record.
Clinical and policy implications
With the current emphasis on measuring clinical outcomes in
health systems and recent plans to use linked data to drive
improvements in the care of patients with cardiovascular
disease,4 13 our study has important implications for practice and
policy. Firstly, we propose much wider use of linked record
sources in commissioning and in research to estimate disease
occurrence and outcome, because of the biases inherent in using
only one source of records. Changing the estimates for incidence
of myocardial infarction could potentially alter the modelled
effect of population based healthcare interventions. Our findings
underscore the importance of international initiatives to
accelerate availability of linked data in America,11-55 in Europe,56
and elsewhere. Secondly, a national strategy for biomedical
informatics is required to tackle manifest system failings: a
single health event should, ideally, have a single record that is
propagated in multiple record systems. Efforts to reform the
process of death certification is already underway,57 but this
needs to be broadened to include other health records. Thirdly,
and more specifically, primary care records could be improved
if the admission date rather than discharge date was used to
record the myocardial infarction (as reflected by the current
“tail” of myocardial infarction records recorded up to 20 days
after admission; see supplementary figure 4) and if acute
myocardial infarction was recorded only for its occurrence rather
than repeated entries for consultations related to a history of
myocardial infarction. Fourthly, disease registries, such as
MINAP, could be improved if embedded in real time clinical
care of all patients with myocardial infarction, rather than the
current situation in which hospitals employ audit staff to
retrospectively enter records on patients in coronary care units.
This needs to be dealt with to obtain a more complete
understanding of the quality of care provided to patients with
acute coronary syndromes.
Future research
Several lines of research are warranted by our findings. Firstly,
research is required to understand how electronic health record
data are coded—historically under-resourced and lacking audit
against quality standards—and how this can be improved.
Secondly, more extensive cross referencing is required against
additional sources of information on myocardial infarction.
These include self reported myocardial infarction (which may
be less dependent on specific setting in the health system),
manual review of all the available local case records (paper and
electronic), and investigation of electronic free text recorded
by general practitioners (for example, diagnoses that are not
recorded using a Read code). Such efforts are underway in the
UK Biobank cohort (n=500 000).3 There is a need for
investigator led cohorts and trials to link with the primary care
record.58Although cancer registries do not record gold standard
diagnostic criteria or cancer stage, it will be important to
understand how linkages with primary care, admission to
hospital, and mortality data compare.59 This is essential for large
studies where manual review of case records is not feasible.
Evaluating the quality of the data available in these linked data
sources is therefore a priority.
Conclusion
Failure to use linked electronic health records from primary
care, hospital care, disease registry, and death certificates may
lead to biased estimates of the incidence and outcome of
myocardial infarction.
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Tables
Table 1| Recording of risk factors in primary care before myocardial infarction recorded in primary care, hospital admission, disease
registry, and death registry sources from 1 January 2003 to 31 March 2009
Cause specific mortality:
ONSDisease registry: MINAPHospital admissions: HESPrimary care: CPRDCharacteristics
401710 35113 83115 819No of patients
81 (73-87)72 (61-81)73 (61-82)73 (61-81)Median (interquartile range) age
(years)
1752 (43.6)3649 (35.3)5072 (36.7)5810 (36.7)Women
849 (21.1)1997 (19.3)2641 (19.1)3211 (20.3)Most deprived fifth*
Smoking:
638 (15.9)2729 (26.4)3608 (26.1)4147 (26.2)Current
2622 (65.3)6194 (59.8)8176 (59.1)9414 (59.5)Former
521 (13.0)1341 (13.0)1745 (12.6)1933 (12.2)None
236 (5.9)87 (0.8)302 (2.2)325 (2.1)Missing
146 (16.1)145 (15.2)145 (15.6)145 (15.4)Mean (SD) systolic blood pressure
(mm Hg)†
64 (1.6)198 (1.9)351 (2.5)385 (2.4)Missing
2919 (72.7)5950 (57.5)7907 (57.2)9149 (57.8)Use of blood pressure lowering drugs
5.2 (0.9)5.4 (0.9)5.4 (0.9)5.4 (0.9)Mean (SD) total serum cholesterol
(mmol/L)†
1101 (27.4)2927 (28.3)4291 (31.0)4646 (29.3)Missing
1.4 (0.3)1.3 (0.3)1.3 (0.3)1.3 (0.3)Mean (SD) HDL cholesterol (mmol/L)†
1703 (42.4)4443 (42.9)6214 (44.9)6985 (44.2)Missing
1757 (43.7)3669 (35.4)4686 (33.9)5632 (35.6)Use of lipid lowering drugs
Framingham hard coronary disease
risk score‡
186 (4.6)851 (8.2)1019 (7.4)1273 (8.0)<10%
1248 (31.1)3181 (30.7)4121 (29.8)4718 (29.8)10-20%
872 (21.7)1841 (17.8)2439 (17.6)2799 (17.7)>20%
1711 (42.6)4478 (43.3)6252 (45.2)7029 (44.4)Missing
927 (23.1)1858 (17.9)2467 (17.8)2885 (18.2)Diabetes
3.2 (1.9)2.4 (1.6)2.4 (1.6)2.5 (1.7)Mean (SD) Charlson index
5.0 (2.3-9.8)3.6 (1.6-7.8)3.5 (1.5-7.7)3.7 (1.6-7.9)Median (interquartile range) primary
care consultation rate per year
CPRD=Clinical Practice Research Datalink; HES=Hospital Episode Statistics; MINAP=Myocardial Ischaemia National Audit Project; ONS=Office for National
Statistics; HDL=high density lipoprotein.
The total number of patients was 21 482. Patients might be represented in more than one column if their myocardial infarction was recorded in more than one
source.
*Assessed by index of multiple deprivation.
†Mean of measurements before date of myocardial infarction.
‡Based on patients with complete data for blood pressure and cholesterol levels.
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Table 2| Information recorded in disease registry (MINAP) within 30 days for non-fatal myocardial infarction recorded in primary care
(Clinical Practice Research Datalink, CPRD) or hospital admissions (Hospital Episode Statistics, HES). Values are numbers (percentages)
unless stated otherwise
Source of myocardial infarction record
Information in MINAP CPRD and HESHESCPRD
600674897224No of patients
Electrocardiographic findings:
3062 (51.0)3455 (46.1)3373 (46.7)ST elevation
1816 (30.2)2485 (33.2)2337 (32.4)Other abnormality
306 (5.1)429 (5.7)389 (5.4)Normal
822 (13.7)1120 (15)1125 (15.6)Not recorded
Cardiac markers:
5121 (85.3)6358 (84.9)6149 (85.1)Raised
299 (5.0)411 (5.5)368 (5.1)Normal
586 (9.8)720 (9.6)707 (9.8)Missing
Peak troponin:
5029 (83.7)6357 (84.9)6109 (84.6)Level recorded
2.34 (0.53-11.6)2.04 (0.45-10.2)2.03 (0.47-10.0)Median (interquartile range) ng/ml
CALIBER diagnosis*:
3064 (51.0)3441 (46.0)3386 (46.9)ST elevation myocardial infarction
2497 (41.6)3410 (45.5)3274 (45.3)Non-ST elevation myocardial infarction
312 (5.2)425 (5.7)384 (5.3)Unstable angina
133 (2.2)213 (2.8)180 (2.5)Other
92.6 (91.9 to 93.3)91.5 (90.8 to 92.1)92.2 (91.6 to 92.8)Positive predictive value (95%CI) for myocardial
infarction†
MINAP=Myocardial Ischaemia National Audit Project.
*MINAP contains details of admissions with suspected acute coronary syndromes. The CALIBER algorithm assigns a diagnosis based on troponin, ECG findings,
and discharge diagnosis recorded in MINAP.
†Positive predictive value of HES or CPRD myocardial infarction is calculated considering a MINAP diagnosis of myocardial infarction as gold standard.
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Figures
Fig 1 Crude incidence of acute fatal and non-fatal myocardial infarction estimated using different combinations of data from
primary care (Clinical Practice Research Datalink), hospital admissions (Hospital Episode Statistics), disease registry
(MINAP, Myocardial Ischaemia National Audit Project), and death registry (Office for National Statistics)
Fig 2 Kaplan Meier curves showing all cause mortality, stratified by record source in 20 819 patients: Clinical Practice
Research Datalink (n=15 819), Hospital Episode Statistics (n=13 831), Myocardial Ischaemia National Audit Project (MINAP)
(n=10 351). Myocardial infarctions recorded by the Office for National Statistics are not shown as they are by definition fatal
on the date of myocardial infarction
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Fig 3 Number and percentage of records recorded in primary care (Clinical Practice Research Datalink), hospital care
(Hospital Episode Statistics), and disease registry (Myocardial Ischaemia National Audit Project) for non-fatal myocardial
infarction across the three sources (n=17 964 patients)
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